Open access · CC-BY
via OpenAlex
Hallmarks of Aging 2.0: Decoding the Molecular Drivers of Human Longevity – Senolytics Vs. Senomorphics as Strategies to Eliminate Senescent “Zombie” Cells
Yash Srivastav Srivastav, Anubha Dhuriya
Journal of Pharmaceutical Research and Integrated Medical Sciences · 2026
Genomic instability
Epigenetic alterations
Mitochondrial dysfunction
Cellular senescence
Chronic inflammation
Senolytics
Human
Review
Abstract
The process of aging is a complicated biological phenomenon that is marked by a loss of functionalities and high susceptibility to illness. Recent developments in geroscience have narrowed down the classical paradigm of aging processes into the so-called telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Hallmarks of Aging(definition) 2.0 where molecular pathways including genomic instability, epigenetic changes, mitochondrial dysfunction(definition), chronic inflammation, and cellular senescence are connected. The buildup of senescent cells also known as the zombie cells has come out as one of the major causes of tissue degeneration during the aging process. These cells are metabolically active and irreversibly differentiate but continue to secrete pro-inflammatory factors referred to as senescence-associated secretory phenotype (SASP). There are two key therapeutic approaches that have been optimized to combat cellular senescence; senolytics(definition), which are specific to eliminate senescent cells, and senomorphics, which inhibit the pathogenic secretory phenotype of senescent cells, but do not kill them. The current review presents an overview of the current results of animal-based experimental research on the molecular hallmark of aging and compares the relative efficacy of senolytic and senomorphic treatment in regulating aging pathways. The article identifies the most important experimental models, mechanisms of action, therapeutic potential and limitations of the existing approaches. The knowledge of these strategies offers an insightful critical view of longevity science and can lead to new possibilities in creating anti-aging interventions to work on basic biological processes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.64063/3049-1681.vol.3.issue4.1
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Srivastav, Y.S., & Dhuriya, A. (2026). Hallmarks of Aging 2.0: Decoding the Molecular Drivers of Human Longevity – Senolytics Vs. Senomorphics as Strategies to Eliminate Senescent “Zombie” Cells. <em>Journal of Pharmaceutical Research and Integrated Medical Sciences</em>. https://doi.org/10.64063/3049-1681.vol.3.issue4.1
Vancouver
Srivastav YS, Dhuriya A. Hallmarks of Aging 2.0: Decoding the Molecular Drivers of Human Longevity – Senolytics Vs. Senomorphics as Strategies to Eliminate Senescent “Zombie” Cells. Journal of Pharmaceutical Research and Integrated Medical Sciences. 2026. doi:10.64063/3049-1681.vol.3.issue4.1.
BibTeX
@article{yash2026Hallma,
title = {Hallmarks of Aging 2.0: Decoding the Molecular Drivers of Human Longevity – Senolytics Vs. Senomorphics as Strategies to Eliminate Senescent “Zombie” Cells},
author = {Yash Srivastav Srivastav and Anubha Dhuriya},
journal = {Journal of Pharmaceutical Research and Integrated Medical Sciences},
year = {2026},
doi = {10.64063/3049-1681.vol.3.issue4.1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PubMed Central 2019
Preprint · CC-BY
Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
American Journal of Physiology-Heart and Circulatory Physiology 2018
Open access · OA
Cellular senescence links aging and diabetes in cardiovascular disease
bioRxiv (Cold Spring Harbor Laboratory) 2023
Preprint · CC-BY
ASK1 promotes inflammation in senescence and aging
Cells 2023
Open access · CC-BY
Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies
Biomolecules 2025
Open access · CC-BY
Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions
Acta Bioclínica 2023
Open access · CC-BY